FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between KK Shah Hospitals IPO and Paragon Fine And Speciality Chemicals IPO.
KK Shah Hospitals IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Paragon Fine And Speciality Chemicals IPO is a SME Book Built Issue proposed to list at NSE SME.
KK Shah Hospitals IPO | Paragon Fine And Speciality Chemicals IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Book Built Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Fedex Securities Pvt Ltd Shreni Shares Limited |
Hem Securities Limited |
Registrar | Bigshare Services Pvt Ltd | Bigshare Services Pvt Ltd |
Market Maker | Rikhav Securities Limited | Hem Finlease Private Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of KK Shah Hospitals IPO is up to ₹8.78 Cr whereas the issue size of the Paragon Fine And Speciality Chemicals IPO is up to ₹51.66 Cr. The final issue price of KK Shah Hospitals IPO is ₹45.00 per share and of Paragon Fine And Speciality Chemicals IPO is ₹100.00 per share.
KK Shah Hospitals IPO | Paragon Fine And Speciality Chemicals IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹95.00 per share | |
Issue Price (Upper) | ₹100.00 per share | |
Issue Price (Final) | ₹45.00 per share | ₹100.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 3000 shares | 1200 shares |
Fresh Issue Size | 19,50,000 shares | 51,66,000 shares |
Fresh Issue Size (Amount) | up to ₹8.78 Cr | up to ₹51.66 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 19,50,000 shares | 51,66,000 shares |
Issue Size Total (Amount) | up to ₹8.78 Cr | up to ₹51.66 Cr |
KK Shah Hospitals IPO opens on Oct 27, 2023, while Paragon Fine And Speciality Chemicals IPO opens on Oct 26, 2023. The closing date of KK Shah Hospitals IPO and Paragon Fine And Speciality Chemicals IPO is Oct 31, 2023, and Oct 30, 2023, respectively.
KK Shah Hospitals IPO | Paragon Fine And Speciality Chemicals IPO | |
---|---|---|
Anchor Bid Date | Oct 25, 2023 | |
Issue Open | Oct 27, 2023 | Oct 26, 2023 |
Issue Close | Oct 31, 2023 | Oct 30, 2023 |
Basis Of Allotment (Tentative) | Nov 03, 2023 | Nov 02, 2023 |
Initiation of Refunds (Tentative) | Nov 06, 2023 | Nov 03, 2023 |
Credit of Share (Tentative) | Nov 06, 2023 | Nov 06, 2023 |
Listing date (Tentative) | Nov 06, 2023 | Nov 03, 2023 |
Anchor Lockin End date 1 | Dec 03, 2023 | Dec 02, 2023 |
Anchor Lockin End date 2 | Feb 01, 2024 | Jan 31, 2024 |
KK Shah Hospitals IPO P/E ratio is 100, as compared to Paragon Fine And Speciality Chemicals IPO P/E ratio of 14.56.
KK Shah Hospitals IPO | Paragon Fine And Speciality Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | KK Shah Hospitals Limited Financial Information (Restated)
|
Paragon Fine And Speciality Chemicals Limited Financial Information (Restated)Paragon Fine And Speciality Chemicals Limited's revenue increased by 24.16% and profit after tax (PAT) rose by 120.3% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 71.36% | 73.60% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 100 | 14.56 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹30.64 Cr. | ₹195.66 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 8.56%% | 56.89%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 5.72%% | 38.86%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹0.45 | ₹6.87 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 4.28%% | 44.29% |
In the KK Shah Hospitals IPO retail investors (RII) are offered 9,24,000 shares while in Paragon Fine And Speciality Chemicals IPO retail investors are offered 9,24,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in KK Shah Hospitals IPO and 9,81,600 shares in Paragon Fine And Speciality Chemicals IPO.
KK Shah Hospitals IPO | Paragon Fine And Speciality Chemicals IPO | |
---|---|---|
Anchor Investor Reserveration | 14,70,000 shares | |
Market Maker Reserveration | 1,02,000 shares | 2,61,600 shares |
QIB | 0 shares | 9,81,600 shares |
NII | 9,24,000 shares | 7,35,600 shares |
RII | 9,24,000 shares | 17,17,200 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 18,48,000 shares | 34,34,400 shares |
KK Shah Hospitals IPO subscribed 13.58x in total, whereas Paragon Fine And Speciality Chemicals IPO subscribed 205.74x.
KK Shah Hospitals IPO | Paragon Fine And Speciality Chemicals IPO | |
---|---|---|
QIB (times) | 81.38x | |
NII (times) | 17.75x | 419.46x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 9.41x | 185.28x |
Employee (times) | ||
Other (times) | ||
Total (times) | 13.58x | 205.74x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|